ARTICLE | Clinical News
AeroDose insulin: Began Phase II testing
December 18, 2000 8:00 AM UTC
AeroGen Inc. (AEGN), Sunnyvale, Calif. Product: AeroDose insulin Business: Metabolic Therapeutic category: Metabolism Target: Insulin receptors Description: Inhaled insulin using AEGN's AeroDose hand-...